In partnership with Citeline, we hosted a podcast featuring industry pioneers, including our CEO and Founder, Fredrik Brag, and Dr. Yan Liu, our Chief Medical Officer.
This enlightening discussion delves into how artificial intelligence (AI) can advance oncology clinical trials, ultimately leading to improved care and outcomes for patients, guided by sponsors committed to pioneering advancements in oncology clinical trials.
Learn more about:
• Advantages of AI-powered imaging for sponsors and patients, using lung cancer as the framework for discussion
• Finding early-stage patients for oncology clinical trials using AI-powered patient data and insights
• And much more about AI’s potential to impact how we leverage imaging data for the advancement of cancer research.
Listen now to our podcast: The Competitive Advantages Of AI-powered Clinical Trial Imaging to Advance Human Health
Want to know more about Median’s AI-powered imaging services for oncology trials? Click here!